End stage renal disease; life‐expectancy; proteinuria after initiation of ACE‐inhibitor‐therapy; proportion of patients with a clinical diagnosis of hypertension; proportion of patients experiencing side effects from ACE‐inhibitors. The gene discussed is ACE; the disease is stage 5 chronic kidney disease.